You are visiting us from Virginia. You are located in HHS Region 3. Your Center is Central East ATTC.

Products and Resources Catalog

Center
Product Type
Target Audience
Language
Keywords
Language
Date Range
Multimedia
This is a recording of the webinar presented by Dr. Brian Fuehrlein on September 24, 2024. After watching this webinar, participants will be able to: Explain prevalence, nomenclature, and diagnostic criteria for alcohol use disorder. Describe the three FDA-approved medications for alcohol use disorder and how best to determine a medication regimen. Demonstrate how to assess risk for alcohol withdrawal syndrome and determine a treatment plan based on risk
Published: September 30, 2024
Print Media
Naloxone is a safe, life-saving medication that can reverse an overdose from opioids. Termed an ‘opioid overdose reversal medication’, Naloxone is easy to carry and administer. This poster illustrates being prepared for an overdose emergency by having an opioid overdose reversal medication on-hand, just like people commonly have a fire extinguisher on-hand for a fire emergency. NALOXONE TRAINING / VIDEOS CDC Naoloxone Training - From CDC, a free one-hour course titled “Talking about Naloxone.”  This course includes an optional risk factors assessment for opioid-related harms and provides communication tips and strategies for engaging in and conducting a conversation with patients about naloxone. CE is available. CDC NALOXONE VIDEO  From CDC, a 30-second video on how to administer naloxone spray to someone experiencing an opioid overdose. GET NALOXONE NOW: NALOXONE TRAINING From the opioid overdose prevention advocacy group Get Naloxone Now, this free course titled: Bystander Training for Opioid Overdose Prevention,Recognition and Response is now available. This training: Describes the U.S. opioid overdose epidemic; Explains the risk of overdose from opioid analgesics and heroin; Teaches how to recognize an opioid overdose; Demonstrates how to respond effectively to an opioid overdose (using animated scenarios, graphic sequences, and narration provided by professional voice actors) and; Links learners to additional resources, including SAMHSA’s overdose toolkits and drug treatment finder. OTHER NALOXONE RESOURCES NALOXONE FREQUENTLY ASKED QUESTIONS (See attachments) CDC FACT SHEET: WHAT YOU NEED TO KNOW ABOUT NALOXONE: FACT SHEET FOR FAMILY AND CAREGIVERS From CDC, this fact sheet teaches family members and caregivers general facts about naloxone including where to get it and how to prevent an opioid overdose.  CDC FACT SHEET: HOW AND WHEN TO USE NALOXONE FOR AN OPIOID OVERDOSE: FACT SHEET FOR FAMILY AND CAREGIVERS  From CDC, this fact sheet teaches family members and caregivers how to identify an opioid overdose and use naloxone.  It also includes the side effects of naloxone. SAMHSA OVERDOSE AND PREVENTION TOOLKIT SAMHSA’s updated Overdose Prevention and Response Toolkit provides guidance to a wide range of individuals on preventing and responding to an overdose. The toolkit also emphasizes that harm reduction and access to treatment are essential aspects of overdose prevention. The toolkit, designed to augment overdose prevention and reversal training, provides guidance on the role of opioid overdose reversal medications, including naloxone and nalmefene, and how to respond to an overdose. It also contains appendices for specific audiences, including people who use drugs (PWUD), people who take prescription opioids, first responders, healthcare practitioners, and others. Request a Hard Copy  
Published: September 24, 2024
Print Media
Naloxone is a safe, life-saving medication that can reverse an overdose from opioids.  Termed an ‘opioid overdose reversal medication’, Naloxone is easy to carry and administer. This poster illustrates the comparison of Naloxone with an automated external defibrillator (AED), another life-saving tool. NALOXONE FREQUENTLY ASKED QUESTIONS  NALOXONE TRAINING / VIDEOS CDC Naloxone Training - From CDC, a free one-hour course titled “Talking about Naloxone.”  This course includes an optional risk factors assessment for opioid-related harms and provides communication tips and strategies for engaging in and conducting a conversation with patients about naloxone. CE is available. CDC NALOXONE VIDEO From CDC, a 30-second video on how to administer naloxone spray to someone experiencing an opioid overdose. GET NALOXONE NOW: NALOXONE TRAINING From the opioid overdose prevention advocacy group Get Naloxone Now, this free course titled: Bystander Training for Opioid Overdose Prevention, Recognition and Response is now available. This training: describes the U.S. opioid overdose epidemic; explains the risk of overdose from opioid analgesics and heroin; teaches how to recognize an opioid overdose; demonstrates how to respond effectively to an opioid overdose (using animated scenarios, graphic sequences, and narration provided by professional voice actors) and; links learners to additional resources, including SAMHSA’s overdose toolkits and drug treatment finder. OTHER NALOXONE RESOURCES CDC FACT SHEET:  WHAT YOU NEED TO KNOW ABOUT NALOXONE: FACT SHEET FOR FAMILY AND CAREGIVERS From CDC, this fact sheet teaches family members and caregivers general facts about naloxone including where to get it and how to prevent an opioid overdose. CDC FACT SHEET:  HOW AND WHEN TO USE NALOXONE FOR AN OPIOID OVERDOSE: FACT SHEET FOR FAMILY AND CAREGIVERS From CDC, this fact sheet teaches family members and caregivers how to identify an opioid overdose and use naloxone.  It also includes the side effects of naloxone. SAMHSA OVERDOSE AND PREVENTION TOOLKIT SAMHSA’s updated Overdose Prevention and Response Toolkit provides guidance to a wide range of individuals on preventing and responding to an overdose. The toolkit also emphasizes that harm reduction and access to treatment are essential aspects of overdose prevention. The toolkit, designed to augment overdose prevention and reversal training, provides guidance on the role of opioid overdose reversal medications, including naloxone and nalmefene, and how to respond to an overdose. It also contains appendices for specific audiences, including people who use drugs (PWUD), people who take prescription opioids, first responders, healthcare practitioners, and others.
Published: September 24, 2024
Multimedia
This webinar presented August 28, 2024, is intended to help substance use disorders and mental health professionals increase cultural awareness to effectively support immigrant and refugee populations seeking treatment for substance use issues. The webinar will focus on identifying the cultural and social challenges surrounding the lack or limited access to treatment in the United States for immigrants and refugees. During the session, ideas to implement culturally tailored tools and strategies to match therapeutic interventions to those cultural and social challenges to increase engagement and effectiveness in outcomes when treating immigrant and refugee clients will be discussed.
Published: August 29, 2024
Multimedia
In this recording of a 90-minute webinar presented August 20, 2024, you will learn more about trauma-informed care principles, cultural humility and partnership development to promote wellbeing for communities who have experienced forced displacement. This engaging webinar will include large-group discussion and will highlight practical approaches and strategies for providing culturally responsive community-based mental health supports for refugees, asylees, and other immigrants who have survived highly stressful and traumatic experiences. Learning Objectives: Apply trauma-informed care principles to working with communities who have experienced forced displacement Understand the importance of cultural humility in treatment and prevention services for this population. identify potential partnerships to foster holistic healing for the clients who have experienced forced displacement.
Published: August 20, 2024
Multimedia
This is a recording and the presentation slides for the webinar held 8/13/24.
Published: August 14, 2024
Multimedia
This is a recording of the webinar presented August 1, 2024 Mental Health Professionals, in general, suffer a critical deficiency in pharmacology knowledge, which impedes their ability to evaluate their patient/clients’ needs and outcomes. An advanced degree in Clinical Psychopharmacology can equip clinicians to better meet the needs of people living with co-occurring disorders (e.g., SUD and other mental health disorders). Click here to watch the presentation online.
Published: August 2, 2024
Multimedia, Presentation Slides
This is the recording of the presentation from July 23, 2024 with Craig Uthe, MD and the slides. Click here to watch the presentation online.
Published: July 29, 2024
Multimedia
This webinar will address and review the latest guidance regarding ethics including ethical responsibility, rural issues related to ethics, South Dakota-specific ethics issues, core values related to ethical practice, ethical decision making models, and context related to therapy and approaches related to ethical practice.
Published: July 16, 2024
Multimedia
Addiction and mental health professionals, medical providers, and recovery support staff are increasingly likely to encounter refugees and others who have experienced forced displacement. This webinar will describe the types of crises that create forced displacement, the experience of the person who was displaced, and appropriate approaches for the professional who serves those who have experienced forced displacement.
Published: July 11, 2024
Multimedia
This is a recording of the webinar presented on June 26, 2024 with Sarah Rowan, MD, and Hermione Hurley, MD. The webinar focused on the advances in the treatment of hepatitis C and the impact of the current medications available for the treatment of the disease. Download Slide Deck
Published: June 27, 2024
Multimedia
This is a recording of the webinar held June 11, 2024. It provided training to give participants a broad understanding of LGBTQ+ culture, demographic terms, the data on population experiences, and tools that can be used in patient care and within an organization as a whole. Presented by Faye Seidler.
Published: June 11, 2024
Multimedia
This is a recording of the session presented June 6, 2024. It was presented to further develop understanding of LGBTQIA2S+ allyship and move toward solidarity. The session aims to help participants identify inclusive practices, skills, and resources to support LGBTQIA2S+ communities and demonstrating a commitment to the practice of allyship. Bio: Dr. Jeff Maliskey (he/him) is the Director for the Pride Center at the University of North Dakota. His work focuses on LGBTQIA2S+ identity support, gender and sexuality education, and advocacy. Dr. Maliskey brings over a decade of student affairs experience working with student affinity-based resources and support centers. As a first-generation, LGBTQ+ scholar, Dr. Jeff Maliskey understands the unique challenges that impact student success in relation to identity. His practice is student-centered, and justice based as means to work towards equity and inclusion in higher education.
Published: June 6, 2024
Multimedia
This is a recording of the webinar presented May 16th, 2024, by Craig Uthe, MD Significant challenges exist in providing safe and adequate care to the patient with co-occurring chronic pain and opioid use disorder. Establishing trust with and empowering this patient to be an active participant in their health is a difficult but necessary step. During this session, we will identify specific polarizing factors of chronic pain and OUD that make this work difficult and discuss strategies to enhance collaboration between patient and caregiver/prescriber that focus on the risk/benefit ratio in longitudinal care.
Published: May 16, 2024
Other
This is the recording and slides for the webinar presented April 24, 2024
Published: April 25, 2024
Multimedia
Adolescent use of electronic cigarettes (vaping) remains steady. Teenagers can easily recite the health risks of cigarette smoking, however, awareness of the risks of vaping and the impact of nicotine on development is variable. This 90-minute webinar will explore how adolescent brain development is altered by nicotine or co-use of nicotine and cannabis. We invite educators, mental health and substance use professionals, and family members to join us in learning about the possible consequences of adolescent vaping. Download PDF
Published: April 17, 2024
Multimedia
This is the recording and a pdf file of the slides used for the March 27, 2024 webinar
Published: March 28, 2024
Multimedia
This is a recording of the webinar presented 2/28/24 along with the PDF copy of the presentation slides.
Published: February 28, 2024
Multimedia
Contingency management is the evidence-based behavioral intervention associated with the most robust evidence for effectively treating individuals with a stimulant use disorder (StimUD). Contingency management provides monetary incentives (such as gift cards) for meeting treatment goals, including stimulant non-use as measured by negative point-of-care urine drug tests (UDTs), rewarding individuals for changing their behaviors. Substance use offers a powerful, immediate reinforcement. Contingency management confronts this challenge by offering immediate financial awards that can help activate the brain’s reward system, thus encouraging the replacement of stimulants with the incentive to achieve a dopamine release. This 90-minute webinar is designed to provide a broad overview of contingency management for treating individuals with a stimulant use disorder (StimUD). Ample time will be provided for group discussion and audience Q&A.   Learning Objectives: At the end of the course, participants will be able to: -Describe at least three (3) patterns and trends regarding the scope of stimulant use in the Western U.S. and beyond. -Identify at least three (3) acute and three (3) chronic effects of psychostimulant drugs on the brain. -Formulate a list of the four (4) essential elements of an evidence‐based, protocol‐driven contingency management program to address stimulant use. -Specify two (2) barriers to implementing contingency management and two (2) strategies to address the barriers.  
Published: January 11, 2024
Multimedia
Virtual service delivery in the substance use and mental health treatment fields is here to stay, according to Meurer-Lynn (2023) and other notable researchers (Aafies- van Doom, et al., 2023; Shore, 2021; etc.) As such, how to blend in-person and virtual service delivery becomes an important question. Hybrid service delivery is a mixture of in-person sessions with videoconferencing sessions and may include phone check-ins. Hybrid service delivery models are known for providing flexibility, especially to clients with access issues, such as clients living in rural areas or those with transportation issues. The exact combination of virtual and in-person sessions ratio is determined by the clinician and patient (Aafies- van Doom, et al., 2023). Recently, many clinics have started to leverage in-person and virtual (video and phone) sessions and negotiate with clients a schedule that will increase engagement and positively impact attendance and adherence to treatment (SAMHSA, 2021). This two-part webinar series will: Provide an overview of substance use clinical services delivered via videoconferencing and telephone Describe and give examples of hybrid service delivery that is based upon the needs of the client, clinician, and provider Illustrate what clinicians and administrators need to consider when initiating hybrid delivery services, like reimbursement, privacy/security issues, staffing, and telephone policies
Published: November 27, 2023
Multimedia
The 4th Edition of the American Society of Addiction Medicine (ASAM) will be out Fall 2023. Treatment providers and program evaluators use patient placement criteria to ensure that clients receive the appropriate level of care based on person-centered needs. This brief 1-hour overview webinar will highlight some of the upcoming changes in the 4th Edition. The content will explore the updated ASAM 6-dimensions and the revised and updated Continuum of Care. Additional training will be announced once the manual is officially released, reviewed, and articulated for treatment providers.
Published: November 21, 2023
Multimedia
Virtual service delivery in the substance use and mental health treatment fields is here to stay, according to Meurer-Lynn (2023) and other notable researchers (Aafies- van Doom, et al., 2023; Shore, 2021; etc.) As such, how to blend in-person and virtual service delivery becomes an important question. Hybrid service delivery is a mixture of in-person sessions with videoconferencing sessions and may include phone check-ins. Hybrid service delivery models are known for providing flexibility, especially to clients with access issues, such as clients living in rural areas or those with transportation issues. The exact combination of virtual and in-person sessions ratio is determined by the clinician and patient (Aafies- van Doom, et al., 2023). Recently, many clinics have started to leverage in-person and virtual (video and phone) sessions and negotiate with clients a schedule that will increase engagement and positively impact attendance and adherence to treatment (SAMHSA, 2021).   This two-part webinar series will: Provide an overview of substance use clinical services delivered via videoconferencing and telephone Describe and give examples of hybrid service delivery that is based upon the needs of the client, clinician, and provider Illustrate what clinicians and administrators need to consider when initiating hybrid delivery services, like reimbursement, privacy/security issues, staffing, and telephone policies  
Published: November 21, 2023
Print Media
In spring of 2023, Mountain Plains ATTC conducted a survey in an effort to better understand the training and technical assistance needs of individuals providing SUD treatment and recovery services in Region 8. The purpose of the survey was to determine providers’ perceptions, practices, and training/technical assistance needs, specifically in relation to harm reduction (HR) services/activities for SUDs. An invitation to participate in the survey was emailed posted on the Mountain Plains ATTC website and was sent to all constituents within Region 8 for which the Mountain Plains ATTC had email addresses. In addition, participants were asked to invite others within their agencies and networks to participate. The survey was completed between March 9 to April 12, 2023. Approval to conduct the survey was obtained from the University of North Dakota Institutional Review Board. Results from this survey will help Mountain Plains ATTC better collaborate with providers and stakeholders throughout the region in the development of new products, training materials, and technical assistance. It is also hoped that this report will provide readers with a snapshot of the perceptions, practices, and technical assistance/training needs of the SUD provider services workforce in Region 8.
Published: October 13, 2023
1 2 3 7

The ATTC Network understands that words have power. A few ATTC products developed prior to 2017 may contain language that does not reflect the ATTCs’ current commitment to using affirming, person-first language. We appreciate your patience as we work to gradually update older materials. For more information about the importance of non-stigmatizing language, see “Destroying Addiction Stigma Once and For All: It’s Time” from the ATTC Network and “Changing Language to Change Care: Stigma and Substance Use Disorders” from the Providers Clinical Support System (PCSS).

map-markermagnifiercrossmenuchevron-down